{"id":"W4379768913","doi":"10.1001/jamaoncol.2023.1374","title":"Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Oncology; Clinical trial; Nivolumab; Immune checkpoint; Internal medicine; Endpoint Determination; Urothelial cancer; Immunotherapy; Cancer; Bladder cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.03366315,0.0005864603,0.01063247,0.001239319,0.00003690686,0.00002931405,0.0002224228,0.001386116,0.0001887594],"category_scores_gemma":[0.00536221,0.0004199015,0.001321879,0.0007992153,0.0003372412,0.00003643736,0.0001666551,0.001437104,0.00004531511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002731046,"about_ca_system_score_gemma":0.002847777,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001642564,"about_ca_topic_score_gemma":0.001986549,"domain_scores_codex":[0.9868091,0.007066942,0.004315356,0.0008939327,0.0003378472,0.0005768765],"domain_scores_gemma":[0.986766,0.0110949,0.001420936,0.0004541287,0.00004586421,0.0002181077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1260206,0.0002154151,0.000007972708,0.00540205,0.0005218238,0.000351373,0.0002868039,2.687292e-7,0.0001589555,0.000004293982,0.00424318,0.8627873],"study_design_scores_gemma":[0.1677293,0.001472429,0.0001340536,0.02295946,0.000838579,0.00004748046,0.00005393917,0.000004400644,0.00005037175,0.00001212893,0.8063414,0.0003564426],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001821141,0.9792099,0.000002107744,0.00657101,0.002292619,0.008354119,0.00008170958,0.00005127657,0.001616115],"genre_scores_gemma":[0.000034616,0.9924316,0.0001338059,0.003152955,0.001381946,0.001758736,0.0001239065,0.0001030494,0.0008793186],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8624309,"threshold_uncertainty_score":0.9999103,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1272674042778694,"score_gpt":0.4600022332855313,"score_spread":0.3327348290076619,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}